Figure 8.
Kaplan-Meier analysis was performed to determine progression-free survival (A) and overall survival (B) of 122 newly diagnosed MM patients according to whether their baseline sCD229 was above or below the cut-off point of 5.0 ng/mL.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.